Dr. Mohammad Memon, MD

Dr. Memon practices at Mediplex Surgery Center in Edison, New Jersey.

Dr. Memon's NPI, 1932101755, was assigned on August 11, 2005. Dr. Memon holds New Jersey license MA33199.

Dr. Memon's primary practice is Mediplex Surgery Center, at 98 James St, Edison, NJ 08820 in Middlesex County. The practice phone is (732) 632-1571.

Dr. Memon's primary practice is Mediplex Surgery Center in Edison, New Jersey. Dr. Memon is also affiliated with JFK University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Memon to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Memon practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Memon's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Memon is licensed in New Jersey.

CMS data shows 343 Medicare services from Dr. Memon across 6 procedure codes in 2024, for 105 Medicare patients. Medicare paid $21,337 for them.

CMS counts 105 Medicare patients who saw Dr. Memon in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Memon's median patient age at 70, with 47% women.

In 2024, Dr. Memon wrote 1,757 Medicare Part D claims for 123 patients. 88% of them were for generic drugs. CMS names the drug for 1,485 of them, across 40 drugs with 11 or more claims each, at $206,109 in total drug cost. In 2023, CMS named 1,430 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Memon for performance year 2024, reported through an alternative payment model (APM). Dr. Memon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Memon in 2020. 2020 was the busiest year, with 3. Dr. Memon has published most often in Cureus.

CMS Open Payments shows 215 general payments to Dr. Memon from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $508.